BeOne Medicines Ltd. (ONC)
BeOne Medicines Market Cap : 42.56B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 43.50B |
| November 16, 2026 | 43.29B |
| November 13, 2026 | 43.84B |
| November 12, 2026 | 43.78B |
| November 11, 2026 | 44.20B |
| November 10, 2026 | 44.63B |
| November 09, 2026 | 43.92B |
| November 06, 2026 | 42.83B |
| November 05, 2026 | 40.76B |
| November 04, 2026 | 39.76B |
| November 03, 2026 | 37.36B |
| November 02, 2026 | 37.63B |
| October 30, 2026 | 38.58B |
| October 29, 2026 | 38.71B |
| October 28, 2026 | 38.89B |
| October 27, 2026 | 38.13B |
| October 26, 2026 | 38.63B |
| October 23, 2026 | 39.34B |
| October 22, 2026 | 39.82B |
| October 21, 2026 | 40.26B |
| October 20, 2026 | 40.05B |
| October 19, 2026 | 38.56B |
| October 16, 2026 | 38.45B |
| October 15, 2026 | 38.97B |
| October 14, 2026 | 36.61B |
| Date | Value |
|---|---|
| October 13, 2026 | 36.36B |
| October 12, 2026 | 36.50B |
| October 09, 2026 | 36.93B |
| October 08, 2026 | 36.47B |
| October 07, 2026 | 37.92B |
| October 06, 2026 | 37.79B |
| October 05, 2026 | 37.67B |
| October 02, 2026 | 37.30B |
| October 01, 2026 | 37.37B |
| September 30, 2026 | 38.12B |
| September 29, 2026 | 38.05B |
| September 28, 2026 | 38.23B |
| September 25, 2026 | 37.59B |
| September 24, 2026 | 37.50B |
| September 23, 2026 | 38.02B |
| September 22, 2026 | 38.34B |
| September 21, 2026 | 38.09B |
| September 18, 2026 | 36.55B |
| September 17, 2026 | 36.82B |
| September 16, 2026 | 36.26B |
| September 15, 2026 | 36.10B |
| September 14, 2026 | 36.86B |
| September 11, 2026 | 36.10B |
| September 10, 2026 | 35.61B |
| September 09, 2026 | 36.56B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 1.042B |
| Santhera Pharmaceuticals Holding AG | 274.57M |
| AC Immune SA | 189.49M |
| CRISPR Therapeutics AG | 4.040B |
| Idorsia Ltd. | 1.268B |
Market Cap Related Metrics
| PE Ratio | 51.27 |
| PS Ratio | 7.084 |
| PEG Ratio | 0.0362 |
| Price to Book Value | 7.928 |
| Price to Free Cash Flow | 32.30 |
| Price | 404.38 |
| Earnings Yield | 1.95% |
| PEGY Ratio | 0.0362 |
| Operating PE Ratio | 39.71 |
| Normalized PE Ratio | 49.91 |